Clinical Trial to Evaluate the Safety and Pharmacokinetic/Pharmacodynamic Characteristics of DW1903

NCT05155072 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastritis

Interventions

DRUG: DW1903
DRUG: DW1903-R1
DRUG: DW1903-R2

Sponsor

Daewon Pharmaceutical Co., Ltd.